199 related articles for article (PubMed ID: 18547805)
1. 3-Alkenyl-2-azetidinones as fatty acid amide hydrolase inhibitors.
Urbach A; Muccioli GG; Stern E; Lambert DM; Marchand-Brynaert J
Bioorg Med Chem Lett; 2008 Jul; 18(14):4163-7. PubMed ID: 18547805
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid amide hydrolase inhibitors. Surprising selectivity of chiral azetidine ureas.
Hart T; Macias AT; Benwell K; Brooks T; D'Alessandro J; Dokurno P; Francis G; Gibbons B; Haymes T; Kennett G; Lightowler S; Mansell H; Matassova N; Misra A; Padfield A; Parsons R; Pratt R; Robertson A; Walls S; Wong M; Roughley S
Bioorg Med Chem Lett; 2009 Aug; 19(15):4241-4. PubMed ID: 19515560
[TBL] [Abstract][Full Text] [Related]
3. Structure based design of novel irreversible FAAH inhibitors.
Wang JL; Bowen SJ; Schweitzer BA; Madsen HM; McDonald J; Pelc MJ; Tenbrink RE; Beidler D; Thorarensen A
Bioorg Med Chem Lett; 2009 Oct; 19(20):5970-4. PubMed ID: 19765986
[TBL] [Abstract][Full Text] [Related]
4. beta-Lactams derived from a carbapenem chiron are selective inhibitors of human fatty acid amide hydrolase versus human monoacylglycerol lipase.
Feledziak M; Michaux C; Urbach A; Labar G; Muccioli GG; Lambert DM; Marchand-Brynaert J
J Med Chem; 2009 Nov; 52(22):7054-68. PubMed ID: 19877691
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of N1/C4-substituted beta-lactams as PPE and HLE inhibitors.
Gérard S; Galleni M; Dive G; Marchand-Brynaert J
Bioorg Med Chem; 2004 Jan; 12(1):129-38. PubMed ID: 14697778
[TBL] [Abstract][Full Text] [Related]
6. Azetidine-2,4-diones (4-oxo-beta-lactams) as scaffolds for designing elastase inhibitors.
Mulchande J; Guedes RC; Tsang WY; Page MI; Moreira R; Iley J
J Med Chem; 2008 Mar; 51(6):1783-90. PubMed ID: 18290604
[TBL] [Abstract][Full Text] [Related]
7. Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase.
Minkkilä A; Saario SM; Käsnänen H; Leppänen J; Poso A; Nevalainen T
J Med Chem; 2008 Nov; 51(22):7057-60. PubMed ID: 18983140
[TBL] [Abstract][Full Text] [Related]
8. Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
Vincent F; Nguyen MT; Emerling DE; Kelly MG; Duncton MA
Bioorg Med Chem Lett; 2009 Dec; 19(23):6793-6. PubMed ID: 19850474
[TBL] [Abstract][Full Text] [Related]
9. An unprecedented reversible mode of action of β-lactams for the inhibition of human fatty acid amide hydrolase (hFAAH).
Feledziak M; Michaux C; Lambert DM; Marchand-Brynaert J
Eur J Med Chem; 2013 Feb; 60():101-11. PubMed ID: 23287055
[TBL] [Abstract][Full Text] [Related]
10. Identification of potent, noncovalent fatty acid amide hydrolase (FAAH) inhibitors.
Gustin DJ; Ma Z; Min X; Li Y; Hedberg C; Guimaraes C; Porter AC; Lindstrom M; Lester-Zeiner D; Xu G; Carlson TJ; Xiao S; Meleza C; Connors R; Wang Z; Kayser F
Bioorg Med Chem Lett; 2011 Apr; 21(8):2492-6. PubMed ID: 21392988
[TBL] [Abstract][Full Text] [Related]
11. 3-Heterocycle-phenyl N-alkylcarbamates as FAAH inhibitors: design, synthesis and 3D-QSAR studies.
Käsnänen H; Myllymäki MJ; Minkkilä A; Kataja AO; Saario SM; Nevalainen T; Koskinen AM; Poso A
ChemMedChem; 2010 Feb; 5(2):213-31. PubMed ID: 20024981
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationships of FAAH inhibitors: cyclohexylcarbamic acid biphenyl esters with chemical modulation at the proximal phenyl ring.
Tarzia G; Duranti A; Gatti G; Piersanti G; Tontini A; Rivara S; Lodola A; Plazzi PV; Mor M; Kathuria S; Piomelli D
ChemMedChem; 2006 Jan; 1(1):130-9. PubMed ID: 16892344
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of unprecedented classes of spiro-beta-lactams and azido-beta-lactams as acyl-CoA:cholesterol acyltransferase inhibitors.
Benfatti F; Cardillo G; Gentilucci L; Tolomelli A
Bioorg Med Chem Lett; 2007 Apr; 17(7):1946-50. PubMed ID: 17275297
[TBL] [Abstract][Full Text] [Related]
14. Design of on-target FAAH inhibitors.
Deutsch DG
Chem Biol; 2005 Nov; 12(11):1157-8. PubMed ID: 16298293
[TBL] [Abstract][Full Text] [Related]
15. SAR and LC/MS studies of β-lactamic inhibitors of human fatty acid amide hydrolase (hFAAH): evidence of a nonhydrolytic process.
Feledziak M; Muccioli GG; Lambert DM; Marchand-Brynaert J
J Med Chem; 2011 Oct; 54(19):6812-23. PubMed ID: 21899370
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and bioactivity of catechin/epicatechin and 2-azetidinone derived chimeric molecules.
Roy B; Chakraborty A; Ghosh SK; Basak A
Bioorg Med Chem Lett; 2009 Dec; 19(24):7007-10. PubMed ID: 19879760
[TBL] [Abstract][Full Text] [Related]
17. A MBP-FAAH fusion protein as a tool to produce human and rat fatty acid amide hydrolase: expression and pharmacological comparison.
Labar G; Vliet FV; Wouters J; Lambert DM
Amino Acids; 2008 Jan; 34(1):127-33. PubMed ID: 17476568
[TBL] [Abstract][Full Text] [Related]
18. Spiro-piperidine azetidinones as potent TRPV1 antagonists.
Xiao D; Palani A; Aslanian R; McKittrick BA; McPhail AT; Correll CC; Phelps PT; Anthes JC; Rindgen D
Bioorg Med Chem Lett; 2009 Feb; 19(3):783-7. PubMed ID: 19114307
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors.
Wang X; Sarris K; Kage K; Zhang D; Brown SP; Kolasa T; Surowy C; El Kouhen OF; Muchmore SW; Brioni JD; Stewart AO
J Med Chem; 2009 Jan; 52(1):170-80. PubMed ID: 19072118
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of endocannabinoid hydrolases FAAH and MAGL inhibitors bearing a benzotriazol-1-yl carboxamide scaffold.
Morera L; Labar G; Ortar G; Lambert DM
Bioorg Med Chem; 2012 Nov; 20(21):6260-75. PubMed ID: 23036333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
